China Gastroparesis Drugs Market Report & Forecast 2021-2027
Table of Contents1 Introduction to Research & Analysis Reports
1.1 Gastroparesis Drugs Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Gastroparesis Drugs Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 China Gastroparesis Drugs Overall Market Size
2.1 China Gastroparesis Drugs Market Size: 2021 VS 2027
2.2 China Gastroparesis Drugs Revenue, Prospects & Forecasts: 2016-2027
2.3 China Gastroparesis Drugs Sales: 2016-2027
3 Company Landscape
3.1 Top Gastroparesis Drugs Players in China Market
3.2 Top China Gastroparesis Drugs Companies Ranked by Revenue
3.3 China Gastroparesis Drugs Revenue by Companies
3.4 China Gastroparesis Drugs Sales by Companies
3.5 China Gastroparesis Drugs Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Gastroparesis Drugs Companies in China Market, by Revenue in 2020
3.7 Manufacturers Gastroparesis Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Gastroparesis Drugs Players in China Market
3.8.1 List of Tier 1 Gastroparesis Drugs Companies in China
3.8.2 List of Tier 2 and Tier 3 Gastroparesis Drugs Companies in China
4 Sights by Type
4.1 Overview
4.1.1 By Type - China Gastroparesis Drugs Market Size Markets, 2021 & 2027
4.1.2 Prokinetic Agents
4.1.3 Antiemetic Agents
4.1.4 Others
4.2 By Type - China Gastroparesis Drugs Revenue & Forecasts
4.2.1 By Type - China Gastroparesis Drugs Revenue, 2016-2021
4.2.2 By Type - China Gastroparesis Drugs Revenue, 2022-2027
4.2.3 By Type - China Gastroparesis Drugs Revenue Market Share, 2016-2027
4.3 By Type - China Gastroparesis Drugs Sales & Forecasts
4.3.1 By Type - China Gastroparesis Drugs Sales, 2016-2021
4.3.2 By Type - China Gastroparesis Drugs Sales, 2022-2027
4.3.3 By Type - China Gastroparesis Drugs Sales Market Share, 2016-2027
4.4 By Type - China Gastroparesis Drugs Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - China Gastroparesis Drugs Market Size, 2021 & 2027
5.1.2 Diabetic Gastroparesis
5.1.3 Idiopathic Gastroparesis
5.2 By Application - China Gastroparesis Drugs Revenue & Forecasts
5.2.1 By Application - China Gastroparesis Drugs Revenue, 2016-2021
5.2.2 By Application - China Gastroparesis Drugs Revenue, 2022-2027
5.2.3 By Application - China Gastroparesis Drugs Revenue Market Share, 2016-2027
5.3 By Application - China Gastroparesis Drugs Sales & Forecasts
5.3.1 By Application - China Gastroparesis Drugs Sales, 2016-2021
5.3.2 By Application - China Gastroparesis Drugs Sales, 2022-2027
5.3.3 By Application - China Gastroparesis Drugs Sales Market Share, 2016-2027
5.4 By Application - China Gastroparesis Drugs Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 Sumitomo
6.1.1 Sumitomo Corporation Information
6.1.2 Sumitomo Overview
6.1.3 Sumitomo Gastroparesis Drugs Sales and Revenue in China Market (2016-2021)
6.1.4 Sumitomo Gastroparesis Drugs Product Description
6.1.5 Sumitomo Recent Developments
6.2 Cadila Pharmaceuticals
6.2.1 Cadila Pharmaceuticals Corporation Information
6.2.2 Cadila Pharmaceuticals Overview
6.2.3 Cadila Pharmaceuticals Gastroparesis Drugs Sales and Revenue in China Market (2016-2021)
6.2.4 Cadila Pharmaceuticals Gastroparesis Drugs Product Description
6.2.5 Cadila Pharmaceuticals Recent Developments
6.3 Sanofi
6.3.1 Sanofi Corporation Information
6.3.2 Sanofi Overview
6.3.3 Sanofi Gastroparesis Drugs Sales and Revenue in China Market (2016-2021)
6.3.4 Sanofi Gastroparesis Drugs Product Description
6.3.5 Sanofi Recent Developments
6.4 Teva
6.4.1 Teva Corporation Information
6.4.2 Teva Overview
6.4.3 Teva Gastroparesis Drugs Sales and Revenue in China Market (2016-2021)
6.4.4 Teva Gastroparesis Drugs Product Description
6.4.5 Teva Recent Developments
6.5 Johnson & Johnson
6.5.1 Johnson & Johnson Corporation Information
6.5.2 Johnson & Johnson Overview
6.5.3 Johnson & Johnson Gastroparesis Drugs Sales and Revenue in China Market (2016-2021)
6.5.4 Johnson & Johnson Gastroparesis Drugs Product Description
6.5.5 Johnson & Johnson Recent Developments
6.6 Pfizer
6.6.1 Pfizer Corporation Information
6.6.2 Pfizer Overview
6.6.3 Pfizer Gastroparesis Drugs Sales and Revenue in China Market (2016-2021)
6.6.4 Pfizer Gastroparesis Drugs Product Description
6.6.5 Pfizer Recent Developments
6.7 Kyowa Kirin Pharmaceuticals
6.7.1 Kyowa Kirin Pharmaceuticals Corporation Information
6.7.2 Kyowa Kirin Pharmaceuticals Overview
6.7.3 Kyowa Kirin Pharmaceuticals Gastroparesis Drugs Sales and Revenue in China Market (2016-2021)
6.7.4 Kyowa Kirin Pharmaceuticals Gastroparesis Drugs Product Description
6.7.5 Kyowa Kirin Pharmaceuticals Recent Developments
6.8 Hanmi Pharm
6.8.1 Hanmi Pharm Corporation Information
6.8.2 Hanmi Pharm Overview
6.8.3 Hanmi Pharm Gastroparesis Drugs Sales and Revenue in China Market (2016-2021)
6.8.4 Hanmi Pharm Gastroparesis Drugs Product Description
6.8.5 Hanmi Pharm Recent Developments
6.9 Ani Pharmaceuticals
6.9.1 Ani Pharmaceuticals Corporation Information
6.9.2 Ani Pharmaceuticals Overview
6.9.3 Ani Pharmaceuticals Gastroparesis Drugs Sales and Revenue in China Market (2016-2021)
6.9.4 Ani Pharmaceuticals Gastroparesis Drugs Product Description
6.9.5 Ani Pharmaceuticals Recent Developments
7 China Gastroparesis Drugs Production Capacity, Analysis
7.1 China Gastroparesis Drugs Production Capacity, 2016-2027
7.2 Gastroparesis Drugs Production Capacity of Key Manufacturers in China Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Gastroparesis Drugs Supply Chain Analysis
9.1 Gastroparesis Drugs Industry Value Chain
9.2 Gastroparesis Drugs Upstream Market
9.3 Gastroparesis Drugs Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Gastroparesis Drugs Distributors and Sales Agents in China Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of TablesTable 1. Key Players of Gastroparesis Drugs in China Market
Table 2. Top Gastroparesis Drugs Players in China Market, Ranking by Revenue (2019)
Table 3. China Gastroparesis Drugs Revenue by Companies, (US$, Mn), 2016-2021
Table 4. China Gastroparesis Drugs Revenue Share by Companies, 2016-2021
Table 5. China Gastroparesis Drugs Sales by Companies, (Kg), 2016-2021
Table 6. China Gastroparesis Drugs Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Gastroparesis Drugs Price (2016-2021) & (US$/mg)
Table 8. Manufacturers Gastroparesis Drugs Product Type
Table 9. List of Tier 1 Gastroparesis Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Gastroparesis Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Prokinetic Agents
Table 12. Major Manufacturers of Antiemetic Agents
Table 13. By Type - China Gastroparesis Drugs Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - China Gastroparesis Drugs Revenue (US$, Mn), 2016-2021
Table 15. By Type - China Gastroparesis Drugs Revenue (US$, Mn), 2022-2027
Table 16. By Type - China Gastroparesis Drugs Sales (Kg), 2016-2021
Table 17. By Type - China Gastroparesis Drugs Sales (Kg), 2022-2027
Table 18. By Application - China Gastroparesis Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - China Gastroparesis Drugs Revenue (US$, Mn), 2016-2021
Table 20. By Application - China Gastroparesis Drugs Revenue (US$, Mn), 2022-2027
Table 21. By Application - China Gastroparesis Drugs Sales (Kg), 2016-2021
Table 22. By Application - China Gastroparesis Drugs Sales (Kg), 2022-2027
Table 23. Sumitomo Corporation Information
Table 24. Sumitomo Description and Major Businesses
Table 25. Sumitomo Gastroparesis Drugs Sales (Kg), Revenue (US$, Mn) and Gross Margin (US$/mg) (2016-2021)
Table 26. Sumitomo Gastroparesis Drugs Product
Table 27. Sumitomo Recent Developments
Table 28. Cadila Pharmaceuticals Corporation Information
Table 29. Cadila Pharmaceuticals Description and Major Businesses
Table 30. Cadila Pharmaceuticals Gastroparesis Drugs Sales (Kg), Revenue (US$, Mn) and Gross Margin (US$/mg) (2016-2021)
Table 31. Cadila Pharmaceuticals Gastroparesis Drugs Product
Table 32. Cadila Pharmaceuticals Recent Developments
Table 33. Sanofi Corporation Information
Table 34. Sanofi Description and Major Businesses
Table 35. Sanofi Gastroparesis Drugs Sales (Kg), Revenue (US$, Mn) and Gross Margin (US$/mg) (2016-2021)
Table 36. Sanofi Gastroparesis Drugs Product
Table 37. Sanofi Recent Developments
Table 38. Teva Corporation Information
Table 39. Teva Description and Major Businesses
Table 40. Teva Gastroparesis Drugs Sales (Kg), Revenue (US$, Mn) and Gross Margin (US$/mg) (2016-2021)
Table 41. Teva Gastroparesis Drugs Product
Table 42. Teva Recent Developments
Table 43. Johnson & Johnson Corporation Information
Table 44. Johnson & Johnson Description and Major Businesses
Table 45. Johnson & Johnson Gastroparesis Drugs Sales (Kg), Revenue (US$, Mn) and Gross Margin (US$/mg) (2016-2021)
Table 46. Johnson & Johnson Gastroparesis Drugs Product
Table 47. Johnson & Johnson Recent Developments
Table 48. Pfizer Corporation Information
Table 49. Pfizer Description and Major Businesses
Table 50. Pfizer Gastroparesis Drugs Sales (Kg), Revenue (US$, Mn) and Gross Margin (US$/mg) (2016-2021)
Table 51. Pfizer Gastroparesis Drugs Product
Table 52. Pfizer Recent Developments
Table 53. Kyowa Kirin Pharmaceuticals Corporation Information
Table 54. Kyowa Kirin Pharmaceuticals Description and Major Businesses
Table 55. Kyowa Kirin Pharmaceuticals Gastroparesis Drugs Sales (Kg), Revenue (US$, Mn) and Gross Margin (US$/mg) (2016-2021)
Table 56. Kyowa Kirin Pharmaceuticals Gastroparesis Drugs Product
Table 57. Kyowa Kirin Pharmaceuticals Recent Developments
Table 58. Hanmi Pharm Corporation Information
Table 59. Hanmi Pharm Description and Major Businesses
Table 60. Hanmi Pharm Gastroparesis Drugs Sales (Kg), Revenue (US$, Mn) and Gross Margin (US$/mg) (2016-2021)
Table 61. Hanmi Pharm Gastroparesis Drugs Product
Table 62. Hanmi Pharm Recent Developments
Table 63. Ani Pharmaceuticals Corporation Information
Table 64. Ani Pharmaceuticals Description and Major Businesses
Table 65. Ani Pharmaceuticals Gastroparesis Drugs Sales (Kg), Revenue (US$, Mn) and Gross Margin (US$/mg) (2016-2021)
Table 66. Ani Pharmaceuticals Gastroparesis Drugs Product
Table 67. Ani Pharmaceuticals Recent Developments
Table 68. Gastroparesis Drugs Production Capacity (Kg) of Key Manufacturers in China Market, 2019-2021 (Kg)
Table 69. China Gastroparesis Drugs Capacity Market Share of Key Manufacturers, 2019-2021
Table 70. Gastroparesis Drugs Market Opportunities & Trends in China Market
Table 71. Gastroparesis Drugs Market Drivers in China Market
Table 72. Gastroparesis Drugs Market Restraints in China Market
Table 73. Gastroparesis Drugs Raw Materials
Table 74. Gastroparesis Drugs Raw Materials Suppliers in China Market
Table 75. Typical Gastroparesis Drugs Downstream
Table 76. Gastroparesis Drugs Downstream Clients in China Market
Table 77. Gastroparesis Drugs Distributors and Sales Agents in China Market
List of FiguresFigure 1. Gastroparesis Drugs Product Picture
Figure 2. Gastroparesis Drugs Segment by Type
Figure 3. Gastroparesis Drugs Segment by Application
Figure 4. China Gastroparesis Drugs Market Overview: 2020
Figure 5. China Gastroparesis Drugs Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. China Gastroparesis Drugs Revenue, 2016-2027 (US$, Mn)
Figure 7. Gastroparesis Drugs Sales in China Market: 2016-2027 (Kg)
Figure 8. The Top 3 and 5 Players Market Share by Gastroparesis Drugs Revenue in 2020
Figure 9. Prokinetic Agents Product Picture
Figure 10. Antiemetic Agents Product Picture
Figure 11. Others Product Picture
Figure 12. By Type - China Gastroparesis Drugs Sales Market Share, 2016-2027
Figure 13. By Type - China Gastroparesis Drugs Revenue Market Share, 2016-2027
Figure 14. By Type - China Gastroparesis Drugs Price (US$/mg), 2016-2027
Figure 15. Diabetic Gastroparesis
Figure 16. Idiopathic Gastroparesis
Figure 17. By Application - China Gastroparesis Drugs Sales Market Share, 2016-2027
Figure 18. By Application - China Gastroparesis Drugs Revenue Market Share, 2016-2027
Figure 19. By Application - China Gastroparesis Drugs Price (US$/mg), 2016-2027
Figure 20. Sumitomo Gastroparesis Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 21. Cadila Pharmaceuticals Gastroparesis Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. Sanofi Gastroparesis Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. Teva Gastroparesis Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Johnson & Johnson Gastroparesis Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. Pfizer Gastroparesis Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. Kyowa Kirin Pharmaceuticals Gastroparesis Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. Hanmi Pharm Gastroparesis Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. Ani Pharmaceuticals Gastroparesis Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 29. China Gastroparesis Drugs Production Capacity (Kg), 2016-2027
Figure 30. Gastroparesis Drugs Industry Value Chain
Figure 31. Marketing Channels